FDA.reportPublic FDA data

Application 208885

Type
ANDA
Sponsor
ZYDUS PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BETAMETHASONE DIPROPIONATEBETAMETHASONE DIPROPIONATECREAM;TOPICALEQ 0.05% BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16714-996Betamethasone dipropionateBetamethasone dipropionateNorthstar Rx LLC.ANDACurrent
16714-996Betamethasone dipropionateBetamethasone dipropionateNorthstar Rx LLC.ANDACurrent
16714-996Betamethasone dipropionateBetamethasone dipropionateNorthstar Rx LLC.ANDACurrent
50090-4679Betamethasone dipropionateBetamethasone dipropionateA-S Medication SolutionsANDACurrent
50090-4679Betamethasone dipropionateBetamethasone dipropionateA-S Medication SolutionsANDACurrent
50090-4679Betamethasone dipropionateBetamethasone dipropionateA-S Medication SolutionsANDACurrent
50090-4680Betamethasone dipropionateBetamethasone dipropionateA-S Medication SolutionsANDACurrent
50090-4680Betamethasone dipropionateBetamethasone dipropionateA-S Medication SolutionsANDACurrent
70518-3562Betamethasone dipropionateBetamethasone dipropionateREMEDYREPACK INC.ANDACurrent
70710-1233Betamethasone dipropionateBetamethasone dipropionateZydus Pharmaceuticals (USA) Inc.ANDACurrent
70710-1233Betamethasone dipropionateBetamethasone dipropionateZydus Pharmaceuticals (USA) Inc.ANDACurrent
70710-1233Betamethasone dipropionateBetamethasone dipropionateZydus Pharmaceuticals USA Inc.ANDACurrent
70771-1380Betamethasone dipropionateBetamethasone dipropionateCadila Healthcare LimitedANDACurrent
70771-1380Betamethasone dipropionateBetamethasone dipropionateCadila Healthcare LimitedANDACurrent
70771-1380Betamethasone dipropionateBetamethasone dipropionateZydus Lifesciences LimitedANDACurrent